A Study of SH009 Injection in Patients With Advanced Solid Tumors.

Clinical trial NCT07390838 · RECRUITING

Trial details

NCT number: NCT07390838
Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Liver Cancer (Locally Advanced or Metastatic)Lung Cancer (NSCLC)Head and Neck Cancer Squamous Cell Carcinoma Breast Cancer (Locally Advanced or Metastatic)Esophageal Cancer Gastric Cancer (GC)Solid Tumor Malignancies

Start date: 2025-05-16
Primary completion: 2026-12-30
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.